Wolverine Trading’s Haemonetics HAE Stock Holding History

Wolverine Trading’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,573	Closed	-$237K	–	5079
2025 Q1	$226K	Sell	3,573 -7,399	-67%	-$503K	﹤0.01%	3818
2024 Q4	$840K	Buy	10,972 +7,980	+267%	+$641K	﹤0.01%	2838
2024 Q3	$239K	Buy	+2,992	New	+$242K	﹤0.01%	3870
2024 Q2	–	Sell	-4,413	Closed	-$377K	–	4777
2024 Q1	$377K	Buy	+4,413	New	+$346K	﹤0.01%	3114
2023 Q4	–	Sell	-5,475	Closed	-$473K	–	4772
2023 Q3	$490K	Buy	+5,475	New	+$489K	﹤0.01%	2792
2021 Q3	–	Sell	-17,100	Closed	-$1.14M	–	6518
2021 Q2	$1.14M	Buy	+17,100	New	+$1.21M	﹤0.01%	2606
2020 Q3	–	Sell	-3,366	Closed	-$294K	–	4774
2020 Q2	$296K	Buy	+3,366	New	+$340K	﹤0.01%	3365
2018 Q3	–	Sell	-3,061	Closed	-$317K	–	5283
2018 Q2	$224K	Hold	3,061	–	–	﹤0.01%	4224
2018 Q1	$224K	Buy	+3,061	New	+$210K	﹤0.01%	4224

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's HAE Position: Q2 2025 in Review

Wolverine Trading sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 3,573 shares — an estimated $237K sold.

Wolverine Trading first reported a position in HAE in Q1 2018 and held it in 9 quarters. The position peaked at $1.14M in Q2 2021. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.

Wolverine Trading reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
Wolverine Trading sold 3,573 Haemonetics shares in Q2 2025, an estimated $237K.
Wolverine Trading first reported a position in Haemonetics in Q1 2018 and held it in 9 quarters.
Wolverine Trading's Haemonetics position peaked at $1.14M in Q2 2021.
298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.